Historical time-to-progression (TTP) and progression-free survival (PFS) in relapsed/refractory neuroblastoma modern-era (2002-14) patients from Children’s Oncology Group (COG) early-phase trials

BACKGROUND: Early-phase trials in relapsed neuroblastoma patients historically used objective “response” of measureable disease (RECIST, without bone/bone marrow assessment) to select agents for further study. Historical cohorts may be small and potentially biased; relapse studies from international...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: London, Wendy B, Bagatell, Rochelle, Weigel, Brenda J, Fox, Elizabeth, Guo, Dongjing, Van Ryn, Collin, Naranjo, Arlene, Park, Julie R
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716896/
https://ncbi.nlm.nih.gov/pubmed/28885700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30934
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados